About
Veocor pioneers cloud-based AI technologies to reduce cost and improve quality of care by diagnosing patients at risk of stroke who benefit from anticoagulation. Veocor has developed the first personalized tool to provide a quantitative assessment of the risk of cardiac thrombus formation and associated stroke. Veocor's technology analyzes standard ultrasound images to provide a quantitative measure of blood flow within the left ventricle, identifying areas of blood stasis which are most susceptible to thrombus formation.
Technologies
Route 53
Amazon AWS
Mobile Friendly
Apache
WordPress.org
Google Font API
YouTube
Google Analytics
Keywords
medical equipment manufacturing
echocardiography analysis
cardiovascular risk stratification
cardiology software
cloud ai for cardiology
medical devices
blood flow visualization
cardiology
blood stasis quantification
fda clearance pathway
standard dicom ultrasound analysis
cloud platform analysis
web-based diagnostic software
ultrasound image analysis
personalized stroke prevention
ai diagnostic tool
standard ultrasound images
ai-powered diagnostic
thrombus risk score
personalized medicine
risk management
left ventricle flow mapping
heart failure risk assessment
ultrasound flow analysis
cardiac imaging analysis
offices of physicians
thrombosis prediction
stroke prevention
clinical decision support
cloud-based medical technology
Company Information
-
Employees 0
Location
San Diego, California, United States, 92092
